FINATI, ELENA

FINATI, ELENA  

Universita' degli Studi di MILANO  

Risultati 1 - 11 di 11 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling 1-ago-2014 R. ParoniL. TerraneoE. FinatiE. VirgiliP. BianciardiG. FaveroF. FraschiniM. Samaja + Article (author) -
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction 1-ott-2012 R. ParoniA. BarassiE. DozioE. FinatiF. GhilardiM.M. CorsiG.V. Melzi d'Eril + Article (author) -
Different routes and formulations of melatonin in critically ill patients : a pharmacokinetic randomized study 1-lug-2019 Mistraletti, GiovanniParoni, RitaUmbrello, MicheleMoro Salihovic, BedranaCoppola, SilviaFroio, SaraFinati, ElenaChiumello, DavideIapichino, Gaetano + Article (author) -
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation 1-nov-2011 L. TerraneoE. FinatiE. VirgiliG. DemartiniL. De AngelisF.L. FraschiniM. SamajaR.C. Paroni + Book Part (author) -
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm 1-mag-2013 E. FinatiG. MistralettiG. IapichinoF. FraschiniR. Paroni Article (author) -
MELATONIN: A PLEIOTROPIC MOLECULE OF NATURAL ORIGIN. EVALUATION OF THE DIFFERENT THERAPEUTIC ACTIVITIES IN ANIMAL MODELS AND / OR HUMAN PATIENTS AND A STUDY OF THE METABOLIC-BIOCHEMICAL PATHWAYS RELATED TO THEM. 19-feb-2013 E. Finati Doctoral Thesis -
Novel strategies to deliver melatonin (in SLN and as cryo-laser therapy) to prostate cancer cells in vivo 1-dic-2010 R. ParoniE. FinatiL. TerraneoM. Samaja + Conference Object -
Novel strategies to deliver melatonin (in SLN and by cryo-laser therapy) to prostate cancer cells 1-mag-2013 E. FinatiE. VirgiliL. TerraneoP. BianciardiM. SamajaR. Paroni + Article (author) -
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN) 1-mag-2012 G. MistralettiE. MantovaniR.C. ParoniE. FinatiF.L. FraschiniG. Iapichino + Conference Object -
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 1-gen-2018 Zuin M.Finati E.Giorgini A. + Article (author) -
Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer 1-nov-2017 L. TerraneoP. BianciardiE. VirgiliE. FinatiM. SamajaR. Paroni Article (author) -